There are plenty of lingering questions about the development of the coronavirus vaccine. How was the pricing decided? Did the public-private partnership with the government work? Who's right in the debate over patent rights and profit sharing?
There's no better person to put these questions to than David Meline, the CFO of Moderna. He joins our podcast this week to talk through the political economy of the Covid-19 vaccine.
